1985
DOI: 10.1016/s0022-3476(85)80540-0
|View full text |Cite
|
Sign up to set email alerts
|

Bloody nipple discharge in infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

1996
1996
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(25 citation statements)
references
References 2 publications
0
25
0
Order By: Relevance
“…Subtle bleeding events, such as bleeding from nipple, umbilical stump, nose, gum and hematospermia, and also fatal intracranial bleedings have been reported [8][9][10]. Another unique feature of factor V is that, in contrast to other coagulation factor inhibitors, the risk of bleeding does not correlate with factor V inhibitor levels, prolongation of PT or aPTT, factor V activity, or the duration of presence of factor V inhibitor, thereby obviating the possibility to predict bleedings [11].…”
Section: Discussionmentioning
confidence: 99%
“…Subtle bleeding events, such as bleeding from nipple, umbilical stump, nose, gum and hematospermia, and also fatal intracranial bleedings have been reported [8][9][10]. Another unique feature of factor V is that, in contrast to other coagulation factor inhibitors, the risk of bleeding does not correlate with factor V inhibitor levels, prolongation of PT or aPTT, factor V activity, or the duration of presence of factor V inhibitor, thereby obviating the possibility to predict bleedings [11].…”
Section: Discussionmentioning
confidence: 99%
“…We also reviewed the literature, and we found that up to date, 25 breasts with BND in 19 patients were reported in the pediatric literature [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17]. The findings of total 39 breasts are summarized according to etiologies and sex in Table 3.…”
Section: Discussionmentioning
confidence: 99%
“…The spectrum of breast disease in the pediatric age group is different from that in adults, and since most lesions are benign, surgical biopsy to rule out the malignancy should be avoided because of the risks of deformity to the developing breast [2]. This has lead to a policy of noninvasive treatment approach of breast masses in this age group by many physicians, especially in female patients [3][4][5][6][7][8][9][10]. However, additional invasive interventions are needed in certain situations such as in cases of infections, duct ectasia, persistent cyst and solid masses for definitive treatment [9][10][11][12][13][14][15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…4 It was observed in association with diffuse breast enlargement, with distinctmass or masses 1,3 or without any appreciable growth. 5,6 It has been reported in early and late infancy, preschool and pubertal children.…”
Section: Discussionmentioning
confidence: 99%
“…Despite limited clinical experience, the extreme rarity of malignant tumors in this age group and its self-limiting nature should reassure parents during the few months needed for cure. 3,5,6,9 The fact that 17 cases of juvenile secretory carcinoma of the breast have presented as asymptomatic swellings and none have given rise to nipple discharge, may support this recommendation. 15 Excisional biopsy should, as a general rule, be avoided, particularly in girls.…”
Section: 35-9mentioning
confidence: 99%